Bioanalytical Testing Services Market Report: Trends, Forecast and Competitive Analysis to 2030

Bioanalytical Testing Services Trends and Forecast

The future of the global bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets. The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030 with a CAGR of 15.2% from 2024 to 2030. The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

A more than 150-page report is developed to help in your business decisions.

Bioanalytical Testing Services by Segment

The study includes a forecast for the global bioanalytical testing services by type, application, end use, and region.

Bioanalytical Testing Services Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Cell-Based Assays
• Bacterial Cell-Based Assays
• Viral Cell-Based Assays
• Virology Testing
• In Vitro Virology Testing
• In Vivo Virology Testing
• Species-Specific Viral PCR Assays
• Method Development, Optimization, And Validation
• Others

Bioanalytical Testing Services Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology

Bioanalytical Testing Services Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical And Biopharmaceutical Companies
• Contract Development And Manufacturing Organizations
• Contract Research Organizations

Bioanalytical Testing Services Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bioanalytical Testing Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioanalytical testing services companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioanalytical testing services companies profiled in this report include-

• Charles River
• Medpace
• WuXi AppTec
• Eurofins Scientific
• IQVIA
• SGS SA
• Laboratory Corporation
• Intertek
• Syneos Health
• ICON

Bioanalytical Testing Services Market Insights

Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Within this market, oncology will remain the largest segment due to growing number of clinical trials conducted for cancer.

APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Features of the Global Bioanalytical Testing Services Market

Market Size Estimates: Bioanalytical testing services market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioanalytical testing services market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bioanalytical testing services market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the bioanalytical testing services market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioanalytical testing services market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bioanalytical testing services market size?

Answer: The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030.

Q2. What is the growth forecast for bioanalytical testing services market?

Answer: The global bioanalytical testing services market is expected to grow with a CAGR of 15.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bioanalytical testing services market?

Answer: The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

Q4. What are the major segments for bioanalytical testing services market?

Answer: The future of the bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets.

Q5. Who are the key bioanalytical testing services market companies?

Answer: Some of the key bioanalytical testing services companies are as follows:

• Charles River
• Medpace
• WuXi AppTec
• Eurofins Scientific
• IQVIA
• SGS SA
• Laboratory Corporation
• Intertek
• Syneos Health
• ICON

Q6. Which bioanalytical testing services market segment will be the largest in future?

Answer: Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Q7. In bioanalytical testing services market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bioanalytical testing services market by type (cell-based assays, bacterial cell-based assays, viral cell-based assays, virology testing, in vitro virology testing, in vivo virology testing, species-specific viral PCR assays, method development, optimization, and validation, and others), application (oncology, neurology, infectious diseases, gastroenterology, and cardiology), end use (pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?